All the congressional rhetoric about escalating U.S. drug prices, all the inquiries into abuses of the system and all the public complaints are coalescing into a unified cry for the U.S. government to do something to bring down the cost of drugs.
"Life-saving treatments only save lives when people can afford them," Rep. Raja Krishnamoorthi (D-Ill.) said in his opening comments at a hearing Wednesday as ranking member of the House Oversight Subcommittee on Health Care.
While delving into innovator drug companies' use of restricted distribution systems to block generic and biosimilar competition, the hearing served as a bipartisan call to action. It also was a warning shot to industry that the president and lawmakers are so fired up about price gouging, anticompetitive actions and secretive pricing deals that they are willing to put aside their political bickering to put teeth to their sound bites.
"Discovering a lifesaving drug is